Ozempic Weight-Loss Drug Linked to Blindness in New Study
Drugmaker Novo Nordisk says its product is safe, while company stock took a hit.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
J.P. Morgan’s tokenized US T-bill products surge to $885M market cap
J.P. Morgan's success in tokenized T-bills highlights a shift towards blockchain in finance, potentially reshaping institutional i...
Polymarket study reveals media impact on prediction market prices
The study highlights the need for traders to diversify news sources and focus on impactful topics to optimize prediction market st...
EIP-8363 sparks debate on ETH’s identity as sound money or productive asset
EIP-8363 could redefine ETH's economic role, impacting staking incentives, decentralization, and its appeal as a deflationary asse...
HIVE Digital Technologies reports 62% increase in monthly Bitcoin production
HIVE's strategic expansion and BTC sales for AI infrastructure highlight a shift towards diversified growth beyond mere Bitcoin ac...
Bitcoin miners are getting a new AI hedge, but it may protect them from the wrong risk
The US derivatives regulator is exploring a market for futures tied to AI computing power just as Bitcoin miners pour hundreds of...
Ripple SEC Case Becomes a Warning for Crypto Lawmakers
Ripple CEO Brad Garlinghouse is using his company’s own legal bill as evidence that Washington’s approach to digital assets has a...